| Elisigen has appointed Daishin Securities as its IPO underwriter and is advancing preparations for a KOSDAQ listing, supported by the clinical progress of NG101 and ongoing business development activities. |
Read Original Article (Korean)
*Note: This link will redirect you to the original source in Korean.